NASDAQ:HZNP - Nasdaq - IE00BQPVQZ61 - Common Stock - Currency: USD
Taking everything into account, HZNP scores 6 out of 10 in our fundamental rating. HZNP was compared to 560 industry peers in the Biotechnology industry. HZNP scores excellent points on both the profitability and health parts. This is a solid base for a good stock. HZNP has a decent growth rate and is not valued too expensively. This makes HZNP very considerable for quality investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 4.71% | ||
ROE | 8.25% | ||
ROIC | 5.35% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 15.58% | ||
PM (TTM) | 12.02% | ||
GM | 75.21% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.48 | ||
Debt/FCF | 2.67 | ||
Altman-Z | 5.1 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 4.27 | ||
Quick Ratio | 4.09 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 25.9 | ||
Fwd PE | 20.14 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 27.79 | ||
EV/EBITDA | 27.94 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
116.3
+0.05 (+0.04%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 25.9 | ||
Fwd PE | 20.14 | ||
P/S | 7.31 | ||
P/FCF | 27.79 | ||
P/OCF | 25.59 | ||
P/B | 5.01 | ||
P/tB | 26.53 | ||
EV/EBITDA | 27.94 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 4.71% | ||
ROE | 8.25% | ||
ROCE | 6.77% | ||
ROIC | 5.35% | ||
ROICexc | 7.58% | ||
ROICexgc | 27.86% | ||
OM | 15.58% | ||
PM (TTM) | 12.02% | ||
GM | 75.21% | ||
FCFM | 26.3% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.48 | ||
Debt/FCF | 2.67 | ||
Debt/EBITDA | 2.66 | ||
Cap/Depr | 21.15% | ||
Cap/Sales | 2.26% | ||
Interest Coverage | 4.07 | ||
Cash Conversion | 108.78% | ||
Profit Quality | 218.81% | ||
Current Ratio | 4.27 | ||
Quick Ratio | 4.09 | ||
Altman-Z | 5.1 |